MXPA04005387A - Composicion farmaceutica para uso en oftalmologia y rinologia. - Google Patents

Composicion farmaceutica para uso en oftalmologia y rinologia.

Info

Publication number
MXPA04005387A
MXPA04005387A MXPA04005387A MXPA04005387A MXPA04005387A MX PA04005387 A MXPA04005387 A MX PA04005387A MX PA04005387 A MXPA04005387 A MX PA04005387A MX PA04005387 A MXPA04005387 A MX PA04005387A MX PA04005387 A MXPA04005387 A MX PA04005387A
Authority
MX
Mexico
Prior art keywords
pharmaceutical composition
hyaluronate
use according
eye
hyaluronic acid
Prior art date
Application number
MXPA04005387A
Other languages
English (en)
Spanish (es)
Inventor
Holzer Frank
Original Assignee
Ursapharm Arzneimittel Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7708986&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MXPA04005387(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ursapharm Arzneimittel Gmbh filed Critical Ursapharm Arzneimittel Gmbh
Publication of MXPA04005387A publication Critical patent/MXPA04005387A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MXPA04005387A 2001-12-12 2002-12-11 Composicion farmaceutica para uso en oftalmologia y rinologia. MXPA04005387A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10161110A DE10161110A1 (de) 2001-12-12 2001-12-12 Pharmazeutische Zusammensetzung zur ophthalmologischen und rhinologischen Anwendung
PCT/DE2002/004527 WO2003049747A1 (de) 2001-12-12 2002-12-11 Pharmazeutische zusammensetzung zur ophtalmologischen und rhinologischen anwendung

Publications (1)

Publication Number Publication Date
MXPA04005387A true MXPA04005387A (es) 2005-03-23

Family

ID=7708986

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA04005387A MXPA04005387A (es) 2001-12-12 2002-12-11 Composicion farmaceutica para uso en oftalmologia y rinologia.

Country Status (11)

Country Link
US (1) US20050164979A1 (de)
EP (1) EP1455803B2 (de)
JP (1) JP3994089B2 (de)
CN (1) CN1310651C (de)
AT (1) ATE300306T1 (de)
AU (1) AU2002360895A1 (de)
CA (1) CA2468771C (de)
DE (2) DE10161110A1 (de)
ES (1) ES2244831T5 (de)
MX (1) MXPA04005387A (de)
WO (1) WO2003049747A1 (de)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10356248A1 (de) 2003-11-13 2005-06-23 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Pharmazeutische Zusammensetzung zur Behandlung von Rhinitiden
DE102004002001A1 (de) 2004-01-14 2005-08-11 Reinmüller, Johannes, Dr.med. Mittel zur Behandlung von entzündlichen Erkrankungen
CN1285382C (zh) * 2004-12-20 2006-11-22 凌沛学 含海藻糖和玻璃酸的鼻腔用药传递系统及其制备方法
DE102005055275A1 (de) 2005-11-17 2007-05-24 Ursapharm Arzneimittel Gmbh & Co. Kg Phosphatfreie pharmazeutische Zusammensetzung sowie deren Verwendung
CA2658646A1 (en) 2006-07-25 2008-01-31 Osmotica Corp. Ophthalmic solutions
JP4987078B2 (ja) * 2006-11-30 2012-07-25 株式会社メニコン 眼科用組成物
KR100927579B1 (ko) * 2006-12-13 2009-11-23 주식회사 엘지생명과학 히아루론산 및/또는 그것의 염을 함유하는 아토피성피부염의 개선 및 치료를 위한 조성물
FR2919185B1 (fr) 2007-07-23 2010-09-10 Ard Sa Utilisation d'acide hyaluronique pour la preparation de compositions destinees a l'amelioration notamment de l'etat des muqueuses
DE202008016517U1 (de) * 2008-12-12 2009-03-05 Ratiopharm Gmbh Wässrige Zusammensetzung enthaltend Dexpanthenol und Natriumchlorid
US9473792B2 (en) 2009-11-06 2016-10-18 Texas Instruments Incorporated Method and system to improve the performance of a video encoder
FR2962044B1 (fr) * 2010-04-21 2013-02-22 Horus Pharma Emulsion lacrymimetique
TW201206418A (en) * 2010-07-02 2012-02-16 Holden Brien Vision Inst Composition for prevention and treatment of contact lens papillary conjunctivitis and allergic eye disease
DE202010012255U1 (de) * 2010-09-07 2010-11-18 Krewel Meuselbach Gmbh Nasenspray
WO2012119261A1 (en) * 2011-03-10 2012-09-13 Biocia Inc. Enhanced artificial mucus composition comprising hyaluronan for the treatment of rhinitis
CN102579478A (zh) * 2012-03-30 2012-07-18 济南康众医药科技开发有限公司 玻璃酸钠在制备药物中的应用
DE202012005650U1 (de) 2012-05-14 2013-05-15 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Kombinationstherapeutikum für die Behandlung von Rhinitis
EP2664330A1 (de) * 2012-05-15 2013-11-20 F. Holzer GmbH Zusammensetzung und Arzneimittel enthaltend Omega-3-Fettsäuren sowie einen Glucosaminoglucan
CN102989045B (zh) * 2012-11-12 2015-02-25 广州共禾医药科技有限公司 生物相容的水性组合物及其用途
WO2016019627A1 (en) * 2014-08-08 2016-02-11 Shenzhen Hightide Biopharmaceutical, Ltd. Liquid formulation compositions, medicament delivery devices, and methods of preparation and use thereof
EP2985019B1 (de) 2014-08-16 2021-10-20 Church & Dwight Co., Inc. Nasale Zusammensetzung mit antiviralen Eigenschaften
EP2985027B1 (de) 2014-08-16 2021-03-31 Church & Dwight Co., Inc. Nasenheilmittel enthaltend ein gemisch von hyaluronsäuren und salzlösung
EP3072503B1 (de) 2015-03-26 2020-09-23 D.M.G. Italia Srl Ophthalmische zusammensetzung für hornhautgewebe
DE102016203696A1 (de) * 2016-03-07 2017-09-07 Ursapharm Arzneimittel Gmbh Ophthalmologische Zusammensetzung
DE102016204472A1 (de) * 2016-03-17 2017-09-21 Ursapharm Arzneimittel Gmbh Kit zur kosmetischen Behandlung des Auges und der Haut und Kosmetikum zur Anwendung am Auge und auf der Haut
TWI609957B (zh) * 2016-06-27 2018-01-01 晶碩光學股份有限公司 用以處理隱形眼鏡之溶液及隱形眼鏡的包裝系統
JP7044467B2 (ja) * 2017-01-16 2022-03-30 ロート製薬株式会社 眼科組成物
DE102017117987A1 (de) * 2017-07-31 2019-01-31 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Neue Zusammensetzung für die nasale Applikation
CN107260657B (zh) * 2017-08-03 2019-02-05 广东莱恩医药研究院有限公司 一种缓释型连翘苷滴眼液及其制备方法
EP3664818B1 (de) * 2017-08-10 2023-11-29 Elixir Ilaç Arastirma Ve Gelistirme A.S. Nasenabschwellungszusammensetzungen mit menthol, dexpanthenol und natriumhyaluronat
US20210145862A1 (en) * 2018-04-18 2021-05-20 i.com medical GmbH High molecular weight hyaluronic acid for enhancing epithelial survival and reconstitution of body surfaces
WO2019202017A1 (en) * 2018-04-18 2019-10-24 i.com medical GmbH High molecular weight hyaluronic acid for treatment and prevention of severe ocular surface disease
US11576926B2 (en) * 2018-09-12 2023-02-14 Neilos S.r.l. Composition for use in the prevention and/or treatment of epistaxis
EP3827818A1 (de) * 2019-11-26 2021-06-02 Warszawskie Zaklady Farmaceutyczne Polfa S.A. Ophthalmische zusammensetzung
CN112870216A (zh) * 2021-01-29 2021-06-01 张宽才 一种药物组合物及制剂和用途
EP4039248A1 (de) * 2021-02-04 2022-08-10 Warszawskie Zaklady Farmaceutyczne Polfa S.A. Ophthalmische zusammensetzung

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4851521A (en) * 1985-07-08 1989-07-25 Fidia, S.P.A. Esters of hyaluronic acid
JPS6479103A (en) * 1987-06-09 1989-03-24 Lion Corp External preparation
DE3832401A1 (de) † 1988-09-23 1990-03-29 Cassella Ag Pharmazeutische zubereitung zur behandlung entzuendeter nasenschleimhaeute
US5141741A (en) * 1988-12-09 1992-08-25 Lion Corporation Anti-sunburn skin-care preparation
IL101056A (en) † 1992-02-24 1997-03-18 Res & Dev Co Ltd Composition for nasal treatment
IT1273011B (it) * 1994-07-25 1997-07-01 Trhecnopharma S A Preparato oftalmico per l'uso come lacrima artificiale
DE19517251A1 (de) * 1995-05-11 1996-11-14 Klosterfrau Mcm Vetrieb Gmbh Verwendung von Dexpanthenol zur Behandlung trockener Nasenschleimhäute
DE19549421C2 (de) † 1995-11-10 1999-11-18 Klosterfrau Mcm Vetrieb Gmbh Pharmazeutische Zubereitung zur Behandlung akuter Rhinitiden
DE19541919C2 (de) † 1995-11-10 1997-11-20 Klosterfrau Mcm Vetrieb Gmbh Pharmazeutische Zubereitung zur Behandlung akuter Rhinitiden
EP0948965B1 (de) * 1997-07-11 2004-06-02 Toray Industries, Inc. Stabile medizinische zusammenstellungen die 4,5-epoxymorphinanderivate enthalten
DE19923829A1 (de) * 1999-05-17 2000-11-23 Ulrich Kluegel Hyaluronat-Wirkstoff-Wasser-Komplex, dessen Herstellung und Verwendung
DE60203691T3 (de) * 2001-01-09 2011-08-18 Louis Johan Wagenaar Verwendung von Dexpanthenol in Kontaktlinsenpflegezusammensetzungen

Also Published As

Publication number Publication date
CN1310651C (zh) 2007-04-18
ATE300306T1 (de) 2005-08-15
CA2468771C (en) 2007-01-30
ES2244831T5 (es) 2016-05-10
ES2244831T3 (es) 2005-12-16
DE50203788D1 (de) 2005-09-01
WO2003049747A1 (de) 2003-06-19
CA2468771A1 (en) 2003-06-19
EP1455803B2 (de) 2016-03-23
WO2003049747A8 (de) 2003-10-02
AU2002360895A1 (en) 2003-06-23
DE10161110A1 (de) 2003-06-26
EP1455803B1 (de) 2005-07-27
CN1602198A (zh) 2005-03-30
US20050164979A1 (en) 2005-07-28
JP2006501133A (ja) 2006-01-12
EP1455803A1 (de) 2004-09-15
JP3994089B2 (ja) 2007-10-17

Similar Documents

Publication Publication Date Title
JP3994089B2 (ja) 眼科学および鼻科学における適用のための薬学的組成物
KR930003117B1 (ko) 황산화 이당류를 활성성분으로 함유하는 염증예방 또는 치료용 제약조성물
Sand et al. Sodium hyaluronate in the treatment of keratoconjunctivitis sicca: a double masked clinical trial
ES2259727T3 (es) Agente oftalmico que contiene heparina.
RU2687275C2 (ru) Слезозаменитель, содержащий гиалуронат натрия и карбоксиметилцеллюлозу
JP2009515921A (ja) デクスパンテノール、カルシウムイオン、およびリン酸塩を含まない薬学的組成物、ならびにカルシウムキレート剤および眼科的に適合性の粘性調節剤の使用
EP2494954B1 (de) Ophthalmische Zusammensetzung basierend auf Laktobionsäure zur Linderung von Hornhautödemen und Entzündungen
US20100190734A1 (en) Method of treating dry eye disease with azithromycin
EP1793836A2 (de) Ophthalmische zusammensetzungen mit gleitmittel, deturgeszenzmittel und glycosaminoglycan und verfahren zu ihrer verwendung
MXPA03011613A (es) Composicion oftalmica que contiene n-acetil-cisteina para el trtamiento de sindrome de ojo seco.
CN110090294A (zh) 具有改善的干燥保护和保留的眼用组合物
US5200180A (en) Pharmaceutical composition for the treatment of the human eye
WO2017098396A1 (en) Synergistic combination of pyrrolidone carboxylic acid and/or salts thereof and hyaluronic acid and/or salts thereof, for use in the treatment and/or prevention of dryness and irritation of the mucosae, and related pharmaceutical formulations
KR20010042032A (ko) 글리코겐을 포함하는 안용액
CN110913867B (zh) 热凝胶化人工泪液
CN107802597B (zh) 一种玻璃酸钠组合物及其制备方法和应用
JP2019514887A (ja) グリコーゲンとヒアルロン酸またはその塩との相乗的組み合わせを含む眼科用組成物
JP2723473B2 (ja) 硫酸化糖類の用途
DE10360425A1 (de) Verwendung von Hyaluronsäure, Hyaluronat und/oder deren Derivate zur Herstellung einer pharmazeutischen Zusammensetzung
CN115803014A (zh) 眼用组合物及其在眼睛疾病治疗中的应用

Legal Events

Date Code Title Description
FG Grant or registration